Clusterstock  Mar 6  Comment 
We talked to Gary Taubes, an expert on obesity and author of the book "Why We Get Fat." He already explained that exercise definitely isn't the only cure for obesity. We asked him about the main dietary ingredient that will help people avoid...
Yahoo  Mar 5  Comment 
Yahoo Finance's Midday Movers is live each weekday at 12pm ET, covering all the latest news on the markets, the economy and the biggest stories of the day.
FiercePharma  Mar 4  Comment 
The FDA isn't happy with Orexigen, which put out some early positive cardio data for obesity drug Contrave on Tuesday. The way the FDA sees it, the data were too early. In fact, it had already asked Orexigen for a second outcomes study because it...
Forbes  Mar 3  Comment 
Orexigen's failure to keep a lid on a key safety analysis of its obesity drug Contrave led the Food and Drug Administration to force it to do a second study in order to prove that the medicine is safe for the heart.
MedPage Today  Mar 3  Comment 
(MedPage Today) -- A surge in obesity and the aging of the population are on a collision course.
Forbes  Mar 3  Comment 
Obesity drug maker Orexigen Therapeutics disclosed this morning that early data from a study of its drug Contrave seem to show that not only does the medicine not cause heart attacks, as some feared, but that it may actually prevent them.
Motley Fool  Mar 3  Comment 
Orexigen Therapeutics looks like it has the first game-changing obesity drug on its hands. Here's what you need to know.
MedPage Today  Mar 2  Comment 
(MedPage Today) -- Bariatric surgeon explains why the procedure offers the best long-term success rate.
MedPage Today  Feb 23  Comment 
(MedPage Today) -- Vitamin D levels were lower in diabetic patients than in normoglycemic patients.
Wall Street Journal  Feb 23  Comment 
Merck & Co. said Monday it has entered a five-year collaboration with NGM Biopharmaceuticals to research and develop drugs that treat diabetes and obesity.


The database did not find the text of a page that it should have found, named "Concept:Obesity,oldid=99022".

This is usually caused by following an outdated diff or history link to a page that has been deleted.

If this is not the case, you may have found a bug in the software. Please report this to an administrator, making note of the URL.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki